Transfusion-dependent Anemia
Drug | Drug Name | Drug Description |
---|---|---|
DB00480 | Lenalidomide | A thalidomide derivative used to treat multiple myeloma and anemia in low to intermediate risk myelodysplastic syndrome. |
Drug | Drug Name | Target | Type |
---|---|---|---|
DB00480 | Lenalidomide | Prostaglandin G/H synthase 2 | target |
DB00480 | Lenalidomide | Tumor necrosis factor ligand superfamily member 11 | target |
DB00480 | Lenalidomide | Cadherin-5 | target |
DB00480 | Lenalidomide | Protein cereblon | target |
DB00480 | Lenalidomide | P-glycoprotein 1 | transporter |
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB01609 | Deferasirox | 2 | Completed | 1 |
DB12281 | Luspatercept | 2 | Recruiting | 1 |
DB00863 | Ranitidine | 3 | Recruiting | 1 |
DB12281 | Luspatercept | 4 | Recruiting | 1 |